Found: 7
Select item for more details and to access through your institution.
Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Effects of Transendocardial Stem Cell Injection on Ventricular Proarrhythmia in Patients with Ischemic Cardiomyopathy: Results from the POSEIDON and TAC-HFT Trials.
- Published in:
- Stem Cells Translational Medicine, 2017, v. 6, n. 5, p. 1366, doi. 10.1002/sctm.16-0328
- By:
- Publication type:
- Article
Concise Review: Review and Perspective of Cell Dosage and Routes of Administration From Preclinical and Clinical Studies of Stem Cell Therapy for Heart Disease.
- Published in:
- Stem Cells Translational Medicine, 2016, v. 5, n. 2, p. 186, doi. 10.5966/sctm.2015-0101
- By:
- Publication type:
- Article
Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Comparison of Allogeneic vs Autologous Bone Marrow-Derived Mesenchymal Stem Cells Delivered by Transendocardial Injection in Patients With Ischemic Cardiomyopathy.
- Published in:
- JAMA: Journal of the American Medical Association, 2012, v. 308, n. 22, p. 2369, doi. 10.1001/jama.2012.25321
- By:
- Publication type:
- Article
Global position paper on cardiovascular regenerative medicine: Scientific statement of the transnational alliance for regenerative therapies in cardiovascular syndromes (TACTICS) international group for the comprehensive cardiovascular application of regenerative medicinal products
- Published in:
- European Heart Journal, 2017, v. 38, n. 33, p. 2532, doi. 10.1093/eurheartj/ehx248
- By:
- Publication type:
- Article